Sensus Healthcare, Inc. (SRTS) vs TELA Bio, Inc. (TELA)
Sensus Healthcare, Inc. and TELA Bio, Inc. are both Medical Devices companies. TELA Bio, Inc. is the larger, with a market value of $57.3M against $47.9M — 1.2× the size. TELA Bio, Inc. grew revenue faster over the last twelve months: 6.09% against −53.4%. TELA Bio, Inc. has the higher net margin (−51.5% vs −88.5%) and the lower return on invested capital (−217.1% vs −38.2%). Across the 17 metrics below, TELA Bio, Inc. leads on 12 and Sensus Healthcare, Inc. on 5.
Valuation
Profitability
| Metric | SRTS | TELA | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.39% | 68.29% | 56.01% |
| Operating margin | (75.72%) | (42.56%) | (15.03%) |
| Net margin | (88.45%) | (51.53%) | (20.40%) |
| Free cash flow margin | (39.82%) | (39.57%) | (7.24%) |
| Return on equity | (34.83%) | 1,232.54% | (15.32%) |
| Return on assets | (30.94%) | (64.71%) | (19.72%) |
| Return on invested capital | (38.22%) | (217.11%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack